119 S832 IS: Ensuring Pathways to Innovative Cures Act of 2025 U.S. Senate 2025-03-04 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

II119th CONGRESS1st SessionS. 832IN THE SENATE OF THE UNITED STATESMarch 4, 2025Mr. Tillis (for himself, Mr. Budd, Mrs. Blackburn, Mr. Daines, and Mr. Lankford) introduced the following bill; which was read twice and referred to the Committee on FinanceA BILLTo amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

1.

Short title

This Act may be cited as the Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025.

2.

Equalizing the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program

Section 1192(e)(1)(A)(ii) of the Social Security Act (42 U.S.C. 1320f–1(e)(1)(A)(ii)) is amended—(1)by striking year, at least 7 and inserting “year—(I)for initial price applicability years 2026 and 2027, at least 7; and(2)by adding at the end the following:(II)for initial price applicability year 2028 and each subsequent initial price applicability year, at least 11 years will have elapsed since the date of such approval; and.